France

Paris company using generative AI and lab robotics to design and synthesise new drug molecules faster.

AI foundation models for biology, spanning molecules to whole organisms

Ambient AI assistant that writes clinical notes for doctors during patient consultations

Led 7 of 14 rounds tracked in France. Serena is a Paris venture capital firm founded in 2008 by Marc…

Led 4 of 12 rounds tracked in France. Kima Ventures backs two startups a week from Paris, around 100 new…

Led 4 of 8 rounds tracked in France. Frst is a Paris seed venture capital firm that invests on day…

A five-minute pitch slot in front of a jury of high-level representatives and international experts drawn from public bodies and institutions, the life sciences industry and the investment community, with potential partners and investors in the room. The winner is recognised as the most innovative life sciences start-up in Europe and honoured on the second day of BioFIT. Selected applicants also get an exclusive 50% discount on a dedicated meeting space inside the exhibition area. · None

The jury awards up to five prizes: the Grand Prix des startups INCYBER, the Prix de la Croissance, the Prix de l'Impact Operationnel, the Prix de la Recherche and the Prix Coup de Coeur for companies under two years old. The grand prize winner receives a partnership package for Forum INCYBER 2027; the other winners each receive a pod in the innovation village plus promotional visibility. Up to 12 finalists are auditioned by a jury of around 20 end-user clients, government ministries and investment funds. · None

A three-minute pitch on stage before a jury of experts, investors and the festival audience, plus exclusive mentoring hours with jury experts, a dedicated article in DL Entreprises and on ledauphine.com, and promotion on the tech&fest social channels · None